| From : | DOMENTE, Silviu <domentes@who.int> |
| To : | M Georgia <tgabunia@moh.gov.ge>; Amiran Gamkrelidze Gmail <gamkrelidzea@gmail.com> |
| Subject : | FW: Strategic considerations for deployment of COVID-19 vaccine and vaccination |
| Cc : | Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Nana Kavtaradze <n.kavtaradze@ncdc.ge> |
| Received On : | 21.09.2020 11:13 |
| Attachments : |
FYI
With best regards,
Silviu
From: DATTA, Siddhartha Sankar
Sent: Monday, September 21, 2020 13:17
To: EU Heads Of COs
Cc: BERDZULI, Nino
Subject: Strategic considerations for deployment of COVID-19 vaccine and vaccination
Dear WR/HCOs,
Greetings from Copenhagen.
As we have discussed on Friday during the IMST call, please find attached the “Strategic Considerations for deployment of COVID-19 vaccines and vaccination” which has been shared with the national
immunization programme managers today.
This document outlines the key strategic considerations for ministries of health, their agencies, national immunization technical advisory groups/committees and relevant public and private sector
authorities in the WHO European Region in preparing for deployment of COVID-19 vaccine and vaccination in their countries. The objective is to allow Member States to identify and address any critical gaps for effective deployment of COVID-19 vaccines.
As new scientific evidence and information related to COVID-19 vaccines become available, a detailed operational guidance and related tools for vaccination and deployment of COVID vaccines in countries
will follow (by mid-November 2020). This will be linked to the guidance and recommendations from the Strategic Advisory Group of Experts on immunization.
Glad if this can be shared from your end with relevant colleagues in the Ministry of Health.
Thanks,
Siddhartha
From: WHO Europe Vaccine-preventable Diseases and Immunization Programme <euvaccine@who.int>
Sent: Monday, September 21, 2020 10:02 AM
To: WHO Europe Vaccine-preventable Diseases and Immunization Programme <euvaccine@who.int>
Cc: DATTA, Siddhartha Sankar <dattas@who.int>; REYNEN-DE KAT, Catharina Margaretha <reynendekatc@who.int>; NAPPI, Gabriella <nappig@who.int>
Subject: Strategic considerations for deployment of COVID-19 vaccine and vaccination; Стратегические соображения относительно обеспечения готовности к организации поставок, распределению вакцин и проведению вакцинации против COVID-19 в Европейском регионе
ВОЗ
|
Dear Colleagues, As our Member States move forward with the decision making on COVID-19 vaccination, it is critical that we have the strategic programmatic considerations for deployment of COVID-19
vaccine and vaccination. Please find attached the document for your reference. This document has been developed by the WHO Regional Office for Europe Working Group on COVID-19 Vaccination in collaboration which engages a broad group of stakeholders under
the overall technical oversight of the European Technical Advisory group of Experts on Immunization. We trust this will be useful for your programme planning and please share this with relevant programme colleagues in your country.
Thanks, Siddhartha |
Уважаемые коллеги, Учитывая тот факт, что государства-члены нашего Региона находятся в процессе принятия чрезвычайно важных решений относительно вакцинации против COVID-19, для всех нас будет важным принять к сведению стратегические программные соображения,
касающиеся организации поставок, распределения вакцин и проведения вакцинации против COVID-19. В связи с этим прикрепляем к данному сообщению соответствующий документ. Документ составлен Рабочей группой по вопросам вакцинации против COVID-19, сформированной в Европейском региональном бюро ВОЗ; к работе над документом были привлечены многие заинтересованные стороны, а общее техническое руководство осуществлялось
Европейской технической консультативной группой экспертов по иммунизации (ЕТКГЭ). Мы надеемся, что этот документ станет полезным ориентиром при планировании вашей программы вакцинации, и просим поделиться им с вашими коллегами, работающими в программе иммунизации в вашей стране. Спасибо, Siddhartha |
|
________________________________________ Dr Siddhartha Sankar Datta Programme Manager Vaccine-preventable Diseases & Immunization (VPI) 2.3.14, UN City, Marmorvej 51, DK-2100 Copenhagen Ø, Denmark Tel.: +45 45 33 7119 GPN: (7)7119 Mobile: +45 23 42 60 66 Fax.: +45 45 33 70 01 http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization |
________________________________________ Д-р Siddhartha Sankar Datta Руководитель, Программа «Болезни, предупреждаемые с помощью вакцин, и иммунизация» (VPI), Отдел страновых программ здравоохранения
(DEC) Европейское региональное бюро ВОЗ 2.3.14,
UN City, Marmorvej 51, DK-2100
Copenhagen Ø, Denmark Tel.: +45 45 33 7119 GPN: (7)7119 Mobile: +45 23 42 60 66 Fax.: +45 45 33 70 01 http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization |